HomeArchive by category 'Antidepressant'

Antidepressant - News and Articles about commonly prescribed drugs

Do you need an antidepressant? | Consumer Reports

Posted in Antidepressant on 4th January 2017

When is it Okay to Take an Antidepressant?

Posted in Antidepressant on 19th November 2016

Superior Medical Solutions Now Offers Free Shipping on Drug Testing Products

Posted in Antidepressant on 18th March 2015

Scottsdale, AZ (PRWEB) February 14, 2012

Superior Medical Solutions, one of the premiere online sites for urine and saliva drug testing products, is now offering free shipping on orders over $ 100. The site features numerous options for a saliva drug test along with home drug test options.

The site features numerous types of 10 panel drug test products along with 5 panel drug test kits. The products provide results within 5 minutes which can be ascertained in a private atmosphere. In addition, oral drug test products are available, which are great because they also provide immediate results but without the need for voiding into a cup.

The drug testing cups are available in many different configurations. They are great for home use for parents establishing a trust relationship with their children, and there are plenty additional reasons for home drug test kits.

There are configurations that allow testing for illicit substances, then configurations that test for prescription drugs, and configurations that test for a combination of both. As little as 3 drug panels are available, or as many as twelve. These include drugs such as Oxycontin, Marijuana, Opiates, Amphetamines, Methamphetamines, Cocaine, Phencyclidine (PCP), Benzodiazepine, Barbiturates, Methadone, Ecstacy, and Tricyclic Antidepressants.

Along with the products for oral and urine drug tests, Superior Medical Solutions also offers products including bracing, durable medical equipment, and hot and cold packs for pain relief.

The free shipping on the site is good for any domestic shipping location, and involves ground shipping. Customer service is available at (888) 885-2929.

###







Rottenstein Law Group Learns of SSRI Antidepressants’ Potential to Cause Male Infertility

Posted in Antidepressant on 13th March 2015

New York, NY (PRWEB) February 15, 2012

SSRIs including Zoloft can decrease a man’s sperm count by as much as 50 percent, according to a Feb. 6, 2012, article that appeared on Fox.com. The antidepressants in the SSRI class can also impair the function of a man’s sperm by changing its shape and impairing its ability to move independently, the article states. These effects can become evident within thirty days of starting an SSRI regimen and they can have a major impact on a male SSRI user’s fertility after just three months of SSRI use.

While the infertility that SSRIs can cause male users doesn’t seem to be permanent, it can take a while for a mans sperm to return to normal even after he has stopped taking SSRIs.

“[T]he situation is reversible and corrects itself once the medication is discontinued,” according to Fox News. “However, it takes 64 days for sperm to fully develop, and a man may not see his levels return to normal in less than three months.”

RLGs Zoloft Lawsuit Information Center, at http://www.zoloftsertralinebirthdefects.com, has features that allow for easy sharing, including links for automatic posting on Facebook and Twitter, specifically to enable visitors to spread the word about Zoloft and the dangers of the drug. The Rottenstein Law Group, a personal injury firm, encourages visitors to link to its sites from their own blogs and websites to spread information about defective medical products and dangerous drugs.

About THE ROTTENSTEIN LAW GROUP

The Rottenstein Law Group is a New York-based law firm that represents clients in dangerous drug lawsuits. The firm was founded by Rochelle Rottenstein, who has more than two decades of experience as a lawyer, to represent clients hurt by d

Contact:

The Rottenstein Law Group, LLP

Rochelle Rottenstein, Esq.

1259 Veeder Drive

Hewlett NY 11557

(212) 933-9500 (office phone)

(212) 933-9980 (facsimile)

rochelle(at)rotlaw(dot)com

http://www.rotlaw.com

###







Rottenstein Law Group Learns of Zoloft Manufacturer’s Motion to Consolidate 59 Cases into One Multidistrict Litigation

Posted in Antidepressant on 25th February 2015

New York, NY (PRWEB) February 01, 2012

Pfizer filed the motion on Jan. 18 under the following multi-district litigation number: MDR 2342. The motion’s stipulations and some background on the cases that the motion seeks to consolidate are outlined in a Jan. 20, 2012, article on Law.com.

As the Law.com article states, all of the cases in the group that is the subject of Pfizer’s motion allege that the children of mothers who took Zoloft during their pregnancies suffered birth defects as a result of that Zoloft use. Pfizer’s motion requests that the consolidated multidistrict litigation of those cases take place in the Southern District of New York, where Pfizer is headquartered. Since New York has three international airports at its disposal, Pfizer asserts in its motion, New York would be a convenient location for the cases’ plaintiffs, who are scattered throughout the country.

Pfizer named the Northern District of Mississippi, the Southern District of Mississippi or the Northern District of Ohio as alternative locations for the proposed multidistrict litigation, stating that those locations would also be convenient for the cases’ many plaintiffs.

Almost 50 of the cases that are the subject of Pfizer’s motion had been removed to the U.S. District Court for the Eastern District of Pennsylvania, according to Law.com. “Pfizer argued in the motion [to consolidate the cases into one multiditsrict litigation] that in the Pennsylvania cases plaintiffs have created an artificial concentration of cases in Pennsylvania by … fraudulently joining Wolters Kluwer Health, a Pennsylvania corporation, as a defendant, in order to defeat diversity jurisdiction,” the Law.com article states.

“The plaintiffs’ theory against Wolters Kluwer Health is that it was negligent in the publication of the risks and benefits of using Zoloft during pregnancy in its patient education monographs,” the Law.com article continues. “Pfizer argues that the division that published the monographs, Medi-Span, is headquartered in Indiana and has offices in Missouri, so Pennsylvania has no ‘real nexus’ to the out-of-state plaintiffs, defendants that the drug company argues are located elsewhere and the underlying allegedly negligent transactions.”

RLGs Zoloft Lawsuit and Birth Defects Information Center, at http://www.zoloftsertralinebirthdefects.com, has features that allow for easy sharing, including links for automatic posting on Facebook and Twitter, specifically to enable visitors to spread the word about Zoloft and the dangers of the drug. The Rottenstein Law Group, a personal injury firm, encourages visitors to link to its sites from their own blogs and websites to spread information about defective medical products and dangerous drugs.

# # #







Page 1 of 105:1 2 3 4 5 6 » Last »